Bundamedik Tbk vs Paramita Bangun Sarana Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Paramita Bangun Sarana Tbk. trades at Rp730 (market cap 2.16T, 424.2K 24h volume). The key difference: Paramita Bangun Sarana Tbk. is the larger of the two by market cap, and Bundamedik Tbk is more actively traded (536.7K versus 424.2K). Which is the better fit depends on your goals.
| BMHS | PBSA | |
|---|---|---|
Market Cap | 1.51T | 2.16T |
Volume | 536.7K | 424.2K |
Lot | 5.37K | 4.24K |
Turnover | 93.41M | 308.64M |
Average Price | 174.05 | 727.59 |
Value | 93.41M | 308.64M |
Indicative Equilibrium Price | 176 | 730 |
Indicative Equilibrium Volume | 100 | 8 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT. Paramita Bangun Sarana Tbk (the Company) was established based on the Notarial Deed No. 33 of Lenny Janis Ishak, S.H., dated November 27, 2002.
Read more on PBSA →